Midgard
G

Genexine

Seoul, South Korea genexine.com From their website, Nov 2026

Work here? Claim this listing

About

Genexine is a biopharmaceutical company in Seoul, Republic of Korea. It develops therapies and enables partnered R&D around cancer, rare diseases, and other biobetter treatments using its hyFc, DNA vaccine, and bioPROTAC platforms.

Genexine is based in Seoul, South Korea. It lists 4 services, including Long-acting hyFc Fusion Platform, New Nanobody Discovery Service and Protein Drug CDAMO Service.

Services

  • Long-acting hyFc Fusion Platform

    Develops long-acting antibody fusion technology by combining IgD hinge flexibility with IgG4 Fc recycling through FcRn.

  • New Nanobody Discovery Service

    Discovers novel nanobody binders against customer-defined antigens, with screening, sequence analysis, binding affinity assessment, production and purification of candidate nanobodies, and affinity maturation.

  • Protein Drug CDAMO Service

    Provides integrated CMC support for protein therapeutics, including upstream and downstream process development, analytical development, quality and regulatory support, technology transfer, and manufacturing support.

  • DNA Vaccine Platform

    Develops plasmid DNA-based therapeutic vaccines for immune responses against viruses and cancer.

How to order from Genexine

They take quote requests by email. You can contact them directly from this page, or request a quote through Midgard.

Capabilities

Assays and studies
  • Antibodies
  • In vivo
  • Immunogenicity
  • NGS
  • E. coli expression
  • Analytical method development
6 more
  • Protein characterization
  • Release testing
  • Stability study
  • Binding affinity assessment
  • Nanobody screening
  • Binder selection
Scale and capacity
  • Scale-up to approximately 200 L
  • Protein sample production for nonclinical studies
  • Culture scale: up to approximately 200 L
Therapeutic areas
  • Cancer
  • Rare diseases
  • Anemia
  • Growth hormone deficiency
  • Type 2 diabetes
  • Obesity
  • Cervical cancer

Modalities and species

Modalities
  • Antibody
  • Bispecific
  • Recombinant protein
  • Vaccine
  • Plasmid DNA
Species and models
E. coli

Industries served

  • Biopharmaceuticals

Details

Quality
QMS (Quality Management System support) · CTD (CTD documentation support)
Based in
Seoul, South Korea
Serves
Korea, the United States, Europe, globally
Phone
+82-2-6098-2600

Similar labs